Accessing the US Capital Markets from Outside the United States – A Primer for UK Life Sciences Companies

Latham & Watkins, in partnership with LifeSci Advisors, is pleased to co-host a series of comprehensive panel discussions on topics that are of particular interest to European-based foreign private issuers and their advisors in the life sciences sector.

This session will focus strictly on the UK life sciences eco-system, and is intended to provide clarity around the legal, investment, and regulatory processes applicable to capital-raising activities in the United States. Topics will cover initial public offerings and alternative routes to going public, as well as what it takes to attract US investors and the benefits of listing in the US.

Speakers

• Michael Baldock, CFO, Abcam
• Wesley Holmes, Life Sciences Corporate Partner, Latham & Watkins
• Chris Maggos, Managing Director, Head of Europe, LifeSci Advisors
• Nicholas Moore, Managing Director, Healthcare, Stifel
• Jordan Saxe, Head of Healthcare, Listings & Capital Markets, Nasdaq

TO REGISTER please click here